[1]
Helvacı, Özant, Yıldırım, S., Yasar, E., Demirezen, A., Akcay, O.F., Alto, K., Erten, Y., Guz, G., Derici, U., Sezenoz, B., Seckin, O. and Isil Ay, E.I.A. 2025. Ferric Carboxymaltose reduces NT-proBNP and enhances functional status in chronic kidney disease and heart failure with preserved ejection fraction . Revista de Nefrología, Diálisis y Trasplante. 45, 03 (Sep. 2025), 146-152.